PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,698,798 | -13.3% | 55,372 | +13.3% | 0.00% | – |
| Q2 2023 | $1,958,322 | -51.9% | 48,873 | -51.0% | 0.00% | – |
| Q1 2023 | $4,067,412 | +118.9% | 99,668 | +107.1% | 0.00% | – |
| Q4 2022 | $1,858,474 | -29.0% | 48,135 | -2.2% | 0.00% | – |
| Q3 2022 | $2,618,000 | -7.9% | 49,224 | +1.0% | 0.00% | – |
| Q2 2022 | $2,842,000 | -19.4% | 48,743 | +5.5% | 0.00% | – |
| Q1 2022 | $3,525,000 | +16685.7% | 46,184 | +13325.6% | 0.00% | – |
| Q4 2021 | $21,000 | +425.0% | 344 | +421.2% | 0.00% | – |
| Q3 2021 | $4,000 | 0.0% | 66 | +6.5% | 0.00% | – |
| Q2 2021 | $4,000 | 0.0% | 62 | -1.6% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 63 | +12.5% | 0.00% | – |
| Q4 2020 | $3,000 | -100.0% | 56 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $8,325,000 | +277400.0% | 138,483 | +247191.1% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 56 | +40.0% | 0.00% | – |
| Q4 2019 | $2,000 | -66.7% | 40 | -68.0% | 0.00% | – |
| Q3 2018 | $6,000 | -100.0% | 125 | -100.0% | 0.00% | -100.0% |
| Q4 2017 | $14,239,000 | -18.4% | 311,919 | -32.9% | 0.00% | 0.0% |
| Q3 2017 | $17,450,000 | -41.1% | 464,719 | -25.2% | 0.00% | -50.0% |
| Q2 2017 | $29,627,000 | -26.1% | 621,119 | -29.3% | 0.00% | -20.0% |
| Q1 2017 | $40,070,000 | -29.3% | 878,719 | -49.9% | 0.01% | -37.5% |
| Q4 2016 | $56,674,000 | -61.5% | 1,754,619 | -59.2% | 0.01% | -60.0% |
| Q3 2016 | $147,175,000 | -21.6% | 4,300,854 | -22.7% | 0.02% | -23.1% |
| Q2 2016 | $187,778,000 | -24.2% | 5,567,088 | +19.1% | 0.03% | -23.5% |
| Q1 2016 | $247,659,000 | -17.8% | 4,674,577 | +19.1% | 0.03% | -17.1% |
| Q4 2015 | $301,442,000 | +145.5% | 3,925,537 | +31.4% | 0.04% | +141.2% |
| Q3 2015 | $122,786,000 | -50.8% | 2,987,498 | -15.3% | 0.02% | -46.9% |
| Q2 2015 | $249,352,000 | -15.6% | 3,525,906 | +6.1% | 0.03% | -15.8% |
| Q1 2015 | $295,323,000 | +4.4% | 3,323,833 | +4.2% | 0.04% | +2.7% |
| Q4 2014 | $282,757,000 | -8.6% | 3,189,222 | -0.1% | 0.04% | -11.9% |
| Q3 2014 | $309,285,000 | +8.4% | 3,191,137 | +2.7% | 0.04% | +10.5% |
| Q2 2014 | $285,388,000 | +30.0% | 3,106,782 | -1.0% | 0.04% | +26.7% |
| Q1 2014 | $219,574,000 | +3.7% | 3,137,220 | -14.8% | 0.03% | 0.0% |
| Q4 2013 | $211,657,000 | +26.4% | 3,681,620 | +5.7% | 0.03% | +15.4% |
| Q3 2013 | $167,477,000 | +114.2% | 3,482,593 | +29.2% | 0.03% | +100.0% |
| Q2 2013 | $78,170,000 | – | 2,695,528 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |